1. Home
  2. VIAV vs IOVA Comparison

VIAV vs IOVA Comparison

Compare VIAV & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Viavi Solutions Inc.

VIAV

Viavi Solutions Inc.

HOLD

Current Price

$18.29

Market Cap

4.3B

Sector

Technology

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$2.81

Market Cap

968.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIAV
IOVA
Founded
1923
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
968.6M
IPO Year
1993
N/A

Fundamental Metrics

Financial Performance
Metric
VIAV
IOVA
Price
$18.29
$2.81
Analyst Decision
Buy
Buy
Analyst Count
8
12
Target Price
$16.79
$10.45
AVG Volume (30 Days)
3.9M
11.6M
Earning Date
01-29-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.06
N/A
Revenue
$1,145,200,000.00
$250,425,000.00
Revenue This Year
$30.31
$60.94
Revenue Next Year
$8.78
$60.85
P/E Ratio
$301.73
N/A
Revenue Growth
15.60
175.62
52 Week Low
$8.10
$1.64
52 Week High
$19.76
$8.15

Technical Indicators

Market Signals
Indicator
VIAV
IOVA
Relative Strength Index (RSI) 57.46 68.34
Support Level $16.91 $2.08
Resistance Level $19.76 $2.60
Average True Range (ATR) 0.78 0.16
MACD -0.11 0.06
Stochastic Oscillator 48.50 97.33

Price Performance

Historical Comparison
VIAV
IOVA

About VIAV Viavi Solutions Inc.

Viavi Solutions Inc. is an international provider of network test, monitoring, and assurance solutions to communications service providers, enterprises, network equipment manufacturers, civil government, military and avionics customers. The company also offers high-performance thin-film optical coatings, providing light management solutions to anti-counterfeiting, 3D sensing, electronics, automotive, defense, and instrumentation markets. Its operating segments include Network Enablement, Service Enablement, and Optical Security and Performance Products. Geographically, it derives a majority of its revenue from the United States. Additionally, it manufactures and sells optical filters for 3D sensing products that allow facial recognition security authentication for mobile devices.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: